COGT Cogent Biosciences, Inc.
P/E
--
Forward P/E
--
Price/Sales
861.15
Beta
0.329
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Cogent Biosciences Enters Commercial Supply Agreement with Hovione for Bezuclastinib
Cogent Biosciences, Inc. has entered into a material Commercial Supply Agreement with Hovione FarmaCiencia S.A. to secure the manufacturing and supply of its...
OrbiMed Advisors boosts stake in Cogent Biosciences by over 420%
Healthcare investment firm OrbiMed Advisors significantly increased its position in Cogent Biosciences during the second quarter of 2026, boosting its stake by...
OrbiMed Adds Major Insurers, Exits Pfizer in Q2 2026 Reshuffle
Healthcare investment specialist OrbiMed Advisors filed its second-quarter 13F for 2026, revealing a portfolio valued at $5.40 billion. The firm's top holdings...